New $ 800 Blood Test Measuring Proteins to Reshape Longevity and Personalized Medicine – ryan
Should you have that Second Cup of Coffee? How About A Little Wine With Dinner? And, is yogurt really your superfood?
Scientists are Getting Closer to Offering Consumers a Blood Test That Coulp People Make Daily Decisions About How to Eat, Drink, and Sleep that more Tailored to their Biology.
The fortComing tests COULD ALSO HELP SHAPE WHAT AGAUABLY FAR MORE IMPORTANT HEALTH DECISIONS, ASSESSING WHATER YOUR BRAIN IS AGING TOO FAST, IF YOUR Kidneys are OK, or if that supplement or drugg is actualy any good.
IT’S CALALED AN AGE AGE TEST, MORE OFFICIALLY (and Scientifically) KNOWN AS “Proteomics” – and it’s the next hot “Biological age” marker that researchers are arguing that better than all the rest.
“If I COULD JUST ONE ONE CLOCK RIGHT NOW, I’D WANT TO THE CLOCK, AND I’D LIKE TO SEE CLINIBALLY AVAILAIL IN OLDER ADULTS,” CERDIOLOGER ERIC Topol, Author of the Recentsseller “Super Agers: an Evidence-Based APPROOACH TO LONGITY,” ” Business Insider. Topol Said Armed With Organ Age Test Results, People Could Become More Proactive Steens of their Own Health, Before it is too.
“We have we had all these layers of data, it’s a whole new for preventing the Disease,” Topol Said. “You see the Relationship with the Women’s Hormones. You see the Relationship with Food and Alcohol. You don’t get that with genes.”
Proteomics COULD GIVE PEOPLE NEW INSIGRS INTO HOW THEIR ARDS ARE WORKING, IN REAL TIME.
istock
A TEST LIKE THIS ISN’T AVAILABLE TO CONSUMERS JUST YET, but it’s already being using by researchers at elite universities and high-end longevity clinics. They Hope it can Become a tool any Doctor COULD USE TO ASSESS PATIENT HEALTH IN THE NEXT FEW YEARS.
A Startup Called Vero, Which was spun out of some foundational proteomics research at stanford university, is hoping to beta Protomics Product for Consumers This Year.
“Knowing your oldest isn’t the point; Changing the trajectory is,” Vero Co-Founder and Ceo Paul Coletta A Crowd Gathered at the Near Future Summit in Malibu, California, Last Month.
Coletta Told Business Insider Vero’s Not Interesting in Doing “Wealthcare.” The Company plans to make its test available to the consumers for around $ 200 a pop, at scale. Their draw Only Requires One Vial of Blood.
Why Meason Proteins Could Be the Key to Better Personalized Medicine
Researchers are Studying Thouusands of Different Proteins in Our Blood, Trying to Get A Better Sense of Which Are The Consuential to Our Health.
Adamkaz/Getty Images
The big promise of proteomics is that it is could be a more precise real-time tool for tracking important but subtle Changes that emperge inside each of us as we are age.
Genetic Testing Can Measure How Our Bodies Are Built, Spoting Vulnerabilities in a Person DNA that might predispose say to health issues. Standard Clinical Measurements Like A Person of Weight, Blood Pressure, Or Cholesterol Readings are a useful proxy for Potential Health Issues.
Then there are the increasingly popular “biological age” tests available to consumers at home. Most of Those Look at “Epigenetic Changes” – How Environmental Factors Affect Our Gene Expression.
Proteomics does something different and new. IT MASURES The Product That Our Bodies Make Based on All Those Genetic and Environmental Inputs: Proteins. IT OFFERS A LIVE ASSESSment of How Your Body Is Running, Not Just How Its Programmed.
If validated in the next few years, these tests could Become in Early Disease Detection and Prevention. They Could Help Influenza All Kinds of Medical Decisions, From Big Ones Like “What Drugs Should I Take?” to little ons like “How does my body Respond to Caffeine or Alcohol?”
Elite Longevity Clinics already use proteomics
Some High-end Longevity Clinics are already forging ahead of proteomics to guide Clinical recommendations, albeit cautiously.
Please help bi improve out busines, tech, and innovation coarse by sharing a bit about your role – it help us tailor content that matters not to people like you.
What is your Job Title?
(1 of 2)
What Products or Services Can You Approve for Purchase in Your Role?
(2 of 2)
Continue
By providing this information, you aggree that business instead may use date to impro you your site experience and for targetted advertising. By Continuing You Agree that you Accept the Terms of Service and Privacy Policy.
Thanks for Sharing Insights About Your Role.
Dr. Evelyne Bischof, A Longevity Physician Who Treats Patients Worldwide, Said She Proteomic Information to Guide Some of the Lifestyle Interventions she recommends to patients.
She May Suggest a More Polyphenol-Rich diet to Someone who SEEMS to have High Inflammation and Neuroinflammation Based on Proteomic Test Results, or May Suggest They Do A Little More Cognitive Training, Based on What Proteomics About How How
Dr. Andrea maier is using proteomics to study changes in her patients over time.
Chi longevity
Dr. Andrea Maier, a professor of medicine and functional aging at the National University of Singapore, Told bi and use this measurement all the time in her longevity clinics. For Her, IT’S JUST A Research Tool, but if the results of her ongoing studies are decent, she hopes to be able to use it clinically in a few years’ time.
“We have been to know what Kind of ‘Ageotype’ a person is, so what type of aging personality are, not from a mental perspective, but from a physical perspective,” maier said. “It ‘really discovery at this moment in time, and at the Edge of Being Clinically Meaningful.”
“Once we have that that was validated tool, we will just add it to our routine testing and we can just tick the box and say, ‘I also want to know this person is a cardiac ager, or a brain ager, or a muscle ager’ Becausee now we have a sensitive parameter – protein – Added, “Maier Said.
The two Big-Name Proteomics Tests Are Olink and Somascan. For Now, Their High-end screening Around Costs $ 400- $ 800 per patient.
“I’M LOING LOTS OF MONEY AT THE BOCAUSE OF PROTOMICS FOR CLINICAL RESEARCH!” Maier Said.
Proteomics Could Soon Help predict who Most Likely to Get Certain Cancers, Fast-Tracking Both prevention and Treatment
Young People Are Getting Diagnosed With Breast and Colon Cancer at Staggering Rates.
ljubaphoto/getty images
Top Aging Researchers at Stanford and Harvard Are Push The Field Forward, Racing to Publish More Novel Insights About The Human Proteome.
The Latest Findings from Harvard Aging Researcher Vadim Gladyshev’s Lab, Published Earlier This Year, Suggest That As We Age, Each May Stand To Benefit From A Slightly Different Antiating Grocery List.
To research this idea, gladyshev lookeed at proteins in the Blood of More than 50,000 People in the Uk, all participants in the uk biobank who are being Regularly Tested and Studied to Learn more about their long-term health. He tracked Their Daily Habits and Self-Reported Routines Like Diet, Occupation, and Prescriptions, Comparing Those Details to How Each Patient’s Organs Were Aging.
He Discovered Some Surpring Connections. Yogurt Eating, Generaly Speaking, Tendered to Be Associated with Better intestinal aging but had relatively no benefit to the arteries. White Wine Drinking, on the Other Hand, SEEMED to Potentially Confer Small Benefit to the Arteries while Wreaking Havoc on the Gut.
“The Main Point is That People Age in Different Ways in Different Organ, and therefore We Need to Find Personalized Interventions that Wauld Fit that Particular Person,” Gladyshev Told. “Through Measuring Proteins, you assess the age of different organs and you say, ‘ok, this person is ld in this artery.’”
For now, there’s too much noise in the data to do more. Dr. Pal Pacher, a senior investigator at the National Institute on Alcohol Abuse and Alcoholism Who Studies organ and Injuries, Told b Thats Proteomics is Simply Not Ready for Clinical use. There’s JUST Too much noise in the date.
But he imagines a future where a more sophistic protein clock culp help link up whic people may be shatt vulnerable to desses like Early Cancer, Kidney Disease, and More. (A California-Based Proteomics Company Called SEER ANNOUNCED LAST WeEkend that is partnership with Korea University to Study Whether Proteomics Can Help More Quickly Diagnose Cancer in Young People in their 20s and 30s.)
“How Beautiful Could it be in The Future?” Maier Said. “Instead of Three Hours of Clinical Investigation;